Clin2
NCT07344324Possibly a fitNot yet recruiting

Stem cell injection for type 2 diabetes

Diabete Type 2Insulin Resistant Diabetes (Mellitus)Obesity

Part of Hormones & metabolism clinical trials.

This trial tests whether injecting your own stem cells into the duodenum (the first part of the small intestine) is safe and possible for people with type 2 diabetes and insulin resistance. The goal is to see if this can help improve blood sugar control.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
25 years to 70 years
Study type
Interventional

Who can take part

  • You are between 25 and 70 years old
  • You have had type 2 diabetes for at least 1 year
  • Your A1C (a measure of blood sugar control over 3 months) is between 7.5% and 10%
  • Your body mass index (BMI) is between 25 and 35
  • You have been on the same diabetes medications for at least 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06789302Not yet recruiting· Phase 2
Stem cell therapy for type 2 diabetes

This trial tests a new stem cell treatment (DT2-SCT) for people with type 2 diabetes who need insulin. It aims to see if the treatment is safe and helps control blood sugar better than a placebo.

NCT07487467Recruiting
Stem cell therapy for type 2 diabetes

This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.

São Jose Do Rio Preto, São Paulo
NCT07693036Recruiting· Phase 1/Phase 2
Exosomes from stem cells for type 2 diabetes

This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.

Beijing
NCT06727721Recruiting· Phase 2
Stem cell therapy for hard-to-treat type 2 diabetes

This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.

Shanghai
NCT07495956Not yet recruiting· Phase 1/Phase 2
MSC therapy for type 2 diabetes

This trial tests whether a type of stem cell treatment (called cfMSC) can help people with long-standing type 2 diabetes who are not getting good blood sugar control from their current treatments. The therapy aims to improve blood sugar levels and may help preserve the body's ability to produce insulin.

Shenzhen, Guangdong
NCT07503028Enrolling by invitation· Early Phase 1
Stem cell therapy for severe low blood sugar in diabetes

This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.

Hefei, Anhui

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.